The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon.

The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon.

OBJECTIVE: Our primary objective was to summarise the known effects of locally administered glucocorticoid on tendon tissue and tendon cells. METHODS: We conducted a systematic review of the scientific literature using the PRISMA and Cochrane guidelines of the Medline database using specific search...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Dean, B, Lostis, E, Oakley, T, Rombach, I, Morrey, M, Carr, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	2014

Documenti analoghi

Glucocorticoids induce specific ion-channel-mediated toxicity in human rotator cuff tendon: a mechanism underpinning the ultimately deleterious effect of steroid injection in tendinopathy?
di: Dean, B, et al.
Pubblicazione: (2014)

Neuronal pathways in tendon healing and tendinopathy--update.
di: Ackermann, P, et al.
Pubblicazione: (2014)

Glucocorticoids in pregnancy
di: Pofi, R, et al.
Pubblicazione: (2019)

Treatment of glucocorticoid- induced hyperglycemia in hospitalized patients - a systematic review and meta- analysis
di: Struja, Tristan, et al.
Pubblicazione: (2024)

The use of platelet-rich plasma for percutaneous treatment of tendinopathies
di: Franklin, S, et al.
Pubblicazione: (2013)

Review: Emerging concepts in the pathogenesis of tendinopathy.
di: Dean, B, et al.
Pubblicazione: (2017)

The localization of the functional glucocorticoid receptor alpha in human bone.
di: Abu, E, et al.
Pubblicazione: (2000)

Glucocorticoids and mepolizumab in eosinophilic asthma.
di: Bel, E, et al.
Pubblicazione: (2014)

Inhaled glucocorticoids and COPD exacerbations.
di: Brightling, C, et al.
Pubblicazione: (2015)

Bone loss and inhaled glucocorticoids.
di: van Staa, T, et al.
Pubblicazione: (2002)

Management of glucocorticoid-induced osteoporosis.
di: Rizzoli, R, et al.
Pubblicazione: (2012)

Epidemiology of glucocorticoid-induced osteoporosis.
di: Dennison, E, et al.
Pubblicazione: (2002)

Modulation of glucocorticoid action and the treatment of type-2 diabetes.
di: Tomlinson, J, et al.
Pubblicazione: (2007)

The peripheral neuronal phenotype is important in the pathogenesis of painful human tendinopathy: a systematic review.
di: Dean, B, et al.
Pubblicazione: (2013)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
di: Van Staa, T, et al.
Pubblicazione: (2004)

Tendon cells isolated from patients with persistent shoulder tendinopathy show dysregulated resolution responses
di: Dakin, SG, et al.
Pubblicazione: (2019)

Glucocorticoids link forest type to local abundance in tropical birds
di: Simone Messina, et al.
Pubblicazione: (2020)

A layered electrospun and woven surgical scaffold to enhance endogenous tendon repair.
di: Hakimi, O, et al.
Pubblicazione: (2015)

Vertical sleeve gastrectomy normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice
di: Akalestou, Elina, et al.
Pubblicazione: (2023)

AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells.
di: Nikolaou, N, et al.
Pubblicazione: (2019)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
di: Robson, J, et al.
Pubblicazione: (2013)

Inflammation: Glucocorticoids turn the monocyte switch.
di: Yona, S, et al.
Pubblicazione: (2007)

A trilogy of glucocorticoid receptor actions
di: Tan, Chek Kun, et al.
Pubblicazione: (2016)

The localisation of glucocorticoid receptors in human bone
di: Abu, E, et al.
Pubblicazione: (1997)

Glucocorticoid circadian rhythms in immune function
di: Olejniczak, I, et al.
Pubblicazione: (2021)

Bone Material Strength by Microindentation in Patients Initiating Glucocorticoids and Effect of Treatments
di: Torres-Del-Pliego, E, et al.
Pubblicazione: (2013)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
di: De Vries, F, et al.
Pubblicazione: (2007)

Pathological tendon histology in early and chronic human patellar tendinopathy
di: Malmgaard-Clausen, NM, et al.
Pubblicazione: (2021)

Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
di: Buckingham, J, et al.
Pubblicazione: (2006)

Pathogenesis of glucocorticoid osteoporosis: Role of tyrosine phosphatases
di: Hulley, P, et al.
Pubblicazione: (2001)

Glucocorticoids: do we know how they work?
di: Saklatvala, J
Pubblicazione: (2002)

Glucocorticoid receptor is required for foetal heart maturation.
di: Rog-Zielinska, E, et al.
Pubblicazione: (2013)

Glucocorticoids and non-alcoholic fatty liver disease.
di: Woods, C, et al.
Pubblicazione: (2015)

Learning pharmacokinetic models for in vivo glucocorticoid activation
di: Bunte, K, et al.
Pubblicazione: (2018)

Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.
di: Espina, B, et al.
Pubblicazione: (2008)

The limitations of using simple definitions of glucocorticoid exposure on the prediction of fracture risk
di: Robinson, D, et al.
Pubblicazione: (2018)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
di: Bel, E, et al.
Pubblicazione: (2014)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
di: van Staa, T, et al.
Pubblicazione: (2007)

Glucocorticoids induce senescence in primary human tenocytes: in vitro and in vivo evidence
di: Poulsen, R, et al.
Pubblicazione: (2013)

Glucocorticoids induce senescence in primary human tenocytes: in vitro and in vivo evidence
di: Poulsen, R, et al.
Pubblicazione: (2013)